Response criteria for phase II studies of supratentorial malignant glioma.

Cited by (1,001)

Items 901–1,000 of 1,001

1. 3-Dimensional Magnetic Resonance Spectroscopic Imaging at 3 Tesla for Early Response Assessment of Glioblastoma Patients During External Beam Radiation Therapy
   Manickam Muruganandham, Patrick P. Clerkin, Brian J. Smith, Carryn M. Anderson, Ann Morris, Arístides Andrés Capizzano, Vincent A. Magnotta, Sarah McGuire, Mark C. Smith, John E. Bayouth et al. · 2014 · International Journal of Radiation Oncology*Biology*Physics
2. An ANOCEF genomic and transcriptomic microarray study of the response to radiotherapy or to alkylating first-line chemotherapy in glioblastoma patients
   François Ducray, Aurélien de Reyniès, Olivier Louis Chinot, Ahmed Idbaïh, Dominique F. Figarella-Branger, Carole Colin, Lucie Karayan, Hervé Chneiweiss, Michel Wager, François M. Vallette et al. · 2010 · Molecular Cancer
3. PIK3CA activating mutations are associated with more disseminated disease at presentation and earlier recurrence in glioblastoma
   Shota Tanaka, Tracy T. Batchelor, Anthony John Iafrate, Dora C. Dias-Santagata, Darrell R. Borger, Leif William Ellisen, Daniel X. Yang, David N. Louis, Daniel P. Cahill, Andrew S. Chi · 2019 · Acta Neuropathologica Communications
4. Reactor-based boron neutron capture therapy for 44 cases of recurrent and refractory high-grade meningiomas with long-term follow-up
   Satoshi Takai, Masahiko Wanibuchi, Shinji Kawabata, Koji Takeuchi, Yoshinori Sakurai, Minoru Suzuki, Koji Ono, Shin‐Ichi Miyatake · 2021 · Neuro-Oncology
5. FLAIR lesion segmentation: Application in patients with brain tumors and acute ischemic stroke
   Moran Artzi, Orna Aizenstein, Tali Jonas‐Kimchi, Vicki Myers, Hen Hallevi, Dafna Ben Bashat · 2013 · European Journal of Radiology
6. Vinorelbine combined with a protracted course of temozolomide for recurrent brain Metastases: a phase I trial
   Antonio M. P. Omuro, Jeffrey J. Raizer, Alexis M. Demopoulos, Mark Gordon Malkin, Lauren E. Abrey · 2006 · Journal of Neuro-Oncology
7. Aggressive Oligodendroglioma: A Chemosensitive Tumor
   John Gregory Cairncross · 1994 · Recent results in cancer research/Recent Results in Cancer Research
8. The Diagnostic Ability of Follow-Up Imaging Biomarkers after Treatment of Glioblastoma in the Temozolomide Era: Implications from Proton MR Spectroscopy and Apparent Diffusion Coefficient Mapping
   Martin Bulik, Tomáš Kazda, Pavel Šlampa, Radim Jančálek · 2015 · BioMed Research International
9. Early post-treatment pseudo-progression amongst glioblastoma multiforme patients treated with radiotherapy and temozolomide: A retrospective analysis
   Ashray Gunjur, Eddie W. F. Lau, Yamna Taouk, G.B. Ryan · 2011 · Journal of Medical Imaging and Radiation Oncology
10. Impact of MRI head placement on glioma response assessment
    Martin Reuter, Elizabeth Robins Gerstner, Otto Rapalino, Tracy T. Batchelor, Bruce Robert Rosen, Bruce R. Fischl · 2014 · Journal of Neuro-Oncology
11. Up-front temozolomide in elderly patients with glioblastoma
    Florence Laigle–Donadey, Dominique F. Figarella-Branger, Olivier Louis Chinot, Luc Taillandier, Stéphanie Cartalat‐Carel, Jérôme Honnorat, Gentian Kaloshi, Jean‐Yves Delattre, Marc Sanson · 2010 · Journal of Neuro-Oncology
12. Intratumoral delivery of mitoxantrone in association with 90-Y radioimmunotherapy (RIT) in recurrent glioblastoma
    Amerigo Boiardi, Mirco Bartolomei, Antonio Silvani, Marica Eoli, Andrea Salmaggi, E. Lamperti, Ida Maddalena Milanesi, A. Botturi, Paola Anna Rocca, Lisa Bodei et al. · 2005 · Journal of Neuro-Oncology
13. A phase II study of the Ras-MAPK signaling pathway inhibitor TLN-4601 in patients with glioblastoma at first progression
    Warren P. Mason, Karl Bélanger, Garth Andrew Nicholas, Isabelle Vallières, David Mathieu, Petr Kavan, Annick Desjardins, Antonio M. P. Omuro, Didier Reymond · 2011 · Journal of Neuro-Oncology
14. LCCC 1025: a phase II study of everolimus, trastuzumab, and vinorelbine to treat progressive HER2-positive breast cancer brain metastases
    Amanda E.D. Van Swearingen, Marni B. Siegel, Allison Mary Deal, Maria J. Sambade, Alan P. Hoyle, David Neil Hayes, Heejoon Jo, Paul Little, Elizabeth Claire Dees, Hyman Bernard Muss et al. · 2018 · Breast Cancer Research and Treatment
15. Prognostic factors in recurrent glioblastoma multiforme and anaplastic astrocytoma treated with selective intra-arterial chemotherapy.
    Kira L. Chow, Yves Pierre Gobin, Timothy Francis Cloughesy, James William Sayre, Juan Pablo Villablanca, Fernando Viñuela · 2000 · PubMed Central
16. A phase II study of carboplatin and chronic high-dose tamoxifen in patients with recurrent malignant glioma
    P. Tang, Gloria B. Roldán, Penny M A Brasher, Dorcas S. Fulton, Wilson Roa, Albert D. Murtha, John Gregory Cairncross, Peter A. Forsyth · 2006 · Journal of Neuro-Oncology
17. Bevacizumab/Irinotecan. Un nouveau traitement actif dans les gliomes de haut grade récidivants : résultats préliminaires d’une étude multicentrique de l’Anocef
    Séverine Guiu, Sophie Taillibert, Olivier Louis Chinot, Luc Taillandier, Jérôme Honnorat, Pierre‐Yves Dietrich, J.-P. Maire, Jean‐Sébastien Guillamo, Boris Guiu, Isabelle Catry‐Thomas et al. · 2008 · Revue Neurologique
18. Phase II study of nimustine, carboplatin, vincristine, and interferon-β with radiotherapy for glioblastoma multiforme: experience of the Kyoto Neuro-Oncology Group
    Tomokazu Aoki, Jun A. Takahashi, Tetsuya Ueba, Natsuo Oya, Masahiro Hiraoka, Kunihiko Matsui, Tsugiya Fukui, Yasuaki Nakashima, Masatsune Ishikawa, Nobuo Hashimoto · 2006 · Journal of neurosurgery
19. Coriolus Versicolor and Ganoderma Lucidum Related Natural Products as an Adjunct Therapy for Cancers: A Systematic Review and Meta-Analysis of Randomized Controlled Trials
    Linda L. D. Zhong, Peijing Yan, Wai Ching Lam, Liang Yao, Zhaoxiang Bian · 2019 · Frontiers in Pharmacology
20. ACNU-based chemotherapy for recurrent glioma in the temozolomide era
    Caroline Hertler, Patrick Roth, Wolfgang Wick, Joachim Peter Steinbach, Michael Linnebank, Michael Weller, Günter Eisele · 2008 · Journal of Neuro-Oncology
21. Treatment of children with recurrent high grade gliomas with a bevacizumab containing regimen
    Chintan Parekh, Rima Fuad Jubran, Anat Erdreich‐Epstein, Ashok Panigrahy, Stefan Blüml, Jonathan L. Finlay, Girish Dhall · 2010 · Journal of Neuro-Oncology
22. Volumetry of [ 11 C]-Methionine Positron Emission Tomographic Uptake as a Prognostic Marker before Treatment of Patients with Malignant Glioma
    Norbert Galldiks, Veronika Dunkl, Lutz Kracht, Stefan Vollmar, Andréas H. Jacobs, Gereon R. Fink, Michael Schroeter · 2012 · Molecular Imaging
23. On differentiation between vasogenic edema and non-enhancing tumor in high-grade glioma patients using a support vector machine classifier based upon pre and post-surgery MRI images
    Anirban Sengupta, Sumeet Agarwal, Pradeep Kumar Gupta, Sunita Ahlawat, Rana Patir, Rakesh Kumar Gupta, Anup K. Singh · 2018 · European Journal of Radiology
24. Emerging antiangiogenic treatments for gliomas – efficacy and safety issues
    Jörg Dietrich, Andrew David Norden, Patrick Yung Wen · 2008 · Current Opinion in Neurology
25. Treatment of recurrent malignant supratentorial gliomas with ifosfamide, carboplatin and etoposide: a phase II study
    Marc Sanson, Alain Améri, Annick Monjour, Tarek Sahmoud, Philippe Ronchin, Michel Poisson, Jean‐Yves Delattre · 1996 · European Journal of Cancer
26. Low-grade gliomas in children: tumor volume response to radiation
    Barbara J. Fisher, Glenn S. Bauman, Christopher E. Leighton, Larry Stitt, J. Gregory Cairncross, David Macdonald · 1998 · Neurosurgical FOCUS
27. Pediatric Phase II Trials of Poly-ICLC in the Management of Newly Diagnosed and Recurrent Brain Tumors
    Lisa L.R. Hartman, John Ross Crawford, Milan Makale, Mehrzad Milburn, Shweta Joshi, Andres Μ. Salazar, Beth Hasenauer, Scott R. VandenBerg, Tobey J. MacDonald, Donald L. Durden · 2013 · Journal of Pediatric Hematology/Oncology
28. Stereotactic 125Iodine Brachytherapy for the Treatment of Singular Brain Metastases: Closing a Gap?
    Maximilian Ingolf Ruge, Bogdana Suchorska, Mohammad Maarouf, Matthias J.R. Runge, Harald Treuer, Jürgen Voges, Volker Sturm · 2011 · Neurosurgery
29. Phase 1 trial of dasatinib plus erlotinib in adults with recurrent malignant glioma
    David A. Reardon, James J. Vredenburgh, Annick Desjardins, Katherine B. Peters, Sith Sathornsumetee, Stevie Threatt, John Howard Sampson, James E. Herndon, April D. Sykes, Frances McSherry et al. · 2012 · Journal of Neuro-Oncology
30. Anti-VEGF Molecular Targeted Therapies in Common Solid Malignancies: Comprehensive Update for Radiologists
    Sree Harsha Tirumani, Alexandra Fairchild, Katherine Maragaret Krajewski, Mizuki Nishino, Stephanie Anne Holler Howard, Akshay Baheti, Michael Hayden Rosenthal, Jyothi Priya Jagannathan, Atul Bhanudas Shinagare, Nikhil H. Ramaiya · 2015 · Radiographics
31. A meta-analysis of temozolomide versus radiotherapy in elderly glioblastoma patients
    Anan Yin, Sang Cai, Yu Hao Dong, Luhua Zhang, Bo-lin Liu, Jinxiang Cheng, Xiang Zhang · 2013 · Journal of Neuro-Oncology
32. Vascular change measured with independent component analysis of dynamic susceptibility contrast MRI predicts bevacizumab response in high-grade glioma
    Peter S. LaViolette, Alex D. Cohen, Melissa A. Prah, Scott D. Rand, Jennifer Connelly, Mark Gordon Malkin, Wade M. Mueller, Kathleen M. Schmainda · 2013 · Neuro-Oncology
33. CNS Anticancer Drug Discovery and Development Conference White Paper
    Victor A. Levin, Peter J. Tonge, James M. Gallo, Marc R. Birtwistle, Arvin C. Dar, Antonio Iavarone, Patrick J. Paddison, Timothy P. Heffron, William F. Elmquist, Jean E. Lachowicz et al. · 2015 · Neuro-Oncology
34. Carbon ion radiotherapy boost in the treatment of glioblastoma: a randomized phase I/III clinical trial
    Lin Kong, Jing Gao, Jiyi Hu, Rong Lü, Jing Yang, Xianxin Qiu, Weixu Hu, Jiade Jay Lu · 2019 · 癌症：英文版
35. Treatment of intracranial metastatic esthesioneuroblastoma
    Marc Charles Chamberlain · 2002 · Cancer
36. Second‐line treatment with carboplatin for recurrent or progressive oligodendroglial tumors after PCV (procarbazine, lomustine, and vincristine) chemotherapy
    Riccardo Soffietti, Mauro Nobile, Roberta Rudà, Marzia Borgognone, Alessandra Costanza, Elena Laguzzi, Roberto Mutani · 2004 · Cancer
37. Cerebrospinal fluid matrix metalloproteinase-9 increases during treatment of recurrent malignant gliomas
    Eric T. Wong, David C. Alsop, Diana Wing Lee, Angela Tam, Loretta Barron, Julianne Bloom, Shiva Gautam, Julian K. Wu · 2008 · Cerebrospinal Fluid Research
38. Combination chemotherapy with 13-cis-retinoic acid and celecoxib in the treatment of glioblastoma multiforme
    Victor A. Levin, Pierre Giglio, Vinay K. Puduvalli, Jacob L. Jochec, Morris D. Groves, W.K. Alfred Yung, Kenneth R. Hess · 2005 · Journal of Neuro-Oncology
39. Treatment of recurrent glioblastoma: can local delivery of mitoxantrone improve survival?
    Amerigo Boiardi, Antonio Silvani, Marica Eoli, E. Lamperti, Andrea Salmaggi, Paola Gaviani, Anna Fiumani, A. Botturi, Chiara Falcone, Alessandra Solari et al. · 2008 · Journal of Neuro-Oncology
40. TP53 Gene Mutations, Nuclear p53 Accumulation, Expression of Waf/p21, Bcl-2, and CD95 (APO-1/Fas) Proteins are not Prognostic Factors in De Novo Glioblastoma Multiforme
    Jürgen A. Kraus, Matthias Wenghoefer, Nicole Glesmann, Svenja Mohr, Martina Beck, Matthias C. Schmidt, Rolf Schröder, Ute Berweiler, Wolfgang Roggendorf, Sabine Diete et al. · 2001 · Journal of Neuro-Oncology
41. Thallium-201 Single-Photon Emission Computed Tomography As an Early Predictor of Outcome in Recurrent Glioma
    Maaike J. Vos, Otto S. Hoekstra, Frederik Barkhof, Johannes Hans Berkhof, J.J. Heimans, C.J. van Groeningen, William Peter Vandertop, Ben J. Slotman, Tjeerd J. Postma · 2003 · Journal of Clinical Oncology
42. Phase II Trial of Radiotherapy After Hyperbaric Oxygenation With Multiagent Chemotherapy (Procarbazine, Nimustine, and Vincristine) for High-Grade Gliomas: Long-Term Results
    Kazuhiko Ogawa, Shogo Ishiuchi, Osamu Inoue, Yoshihiko Yoshii, Atsushi Saitô, Takashi Watanabe, Shiro Iraha, Takafumi Toita, Yasumasa Kakinohana, Takuro Ariga et al. · 2011 · International Journal of Radiation Oncology*Biology*Physics
43. Targeted Toxins in Brain Tumor Therapy
    Yan Michael Li, Walter A. Hall · 2010 · Toxins
44. Reliability of Semi-Automated Segmentations in Glioblastoma
    Thomas S. Huber, Georgina Alber, Stefanie J. Bette, Tobias Boeckh‐Behrens, Jens Gempt, Florian A. Ringel, Esther Alberts, Claus Zimmer, Jan Stefan Bauer · 2015 · Clinical Neuroradiology
45. Phase I and Pharmacokinetic Study of Cetuximab and Irinotecan in Children With Refractory Solid Tumors: A Study of the Pediatric Oncology Experimental Therapeutic Investigators' Consortium
    Tanya Maria Trippett, Cynthia E. Herzog, James A. Whitlock, Johannes Ernst Alexander Wolff, John F. Kuttesch, Rochelle Bagatell, Stephen P. Hunger, Jessica Boklan, Amy Smith, Robert John Arceci et al. · 2009 · Journal of Clinical Oncology
46. Antiangiogenic therapy for patients with glioblastoma: current challenges in imaging and future directions
    Manmeet Singh Ahluwalia, Patrick Yung Wen · 2011 · Expert Review of Anticancer Therapy
47. Dogs are man's best friend: in sickness and in health
    R. Timothy Bentley, Atique U. Ahmed, Amy B. Yanke, Aaron Cohen‐Gadol, Mahua Dey · 2016 · Neuro-Oncology
48. Amino Acid PET – An Imaging Option to Identify Treatment Response, Posttherapeutic Effects, and Tumor Recurrence?
    Norbert Galldiks, Karl‐Josef Langen · 2016 · Frontiers in Neurology
49. High-Grade Glioma Management and Response Assessment—Recent Advances and Current Challenges
    Maria Khan, Ankur Markand Sharma, Marshall W. Pitz, Shaun K. Loewen, Harvey Charles Quon, Anne-Marie Poulin, Marco Essig · 2016 · Current Oncology
50. Differentiation between vasogenic edema and infiltrative tumor in patients with high‐grade gliomas using texture patch‐based analysis
    Moran Artzi, Gilad Liberman, Deborah T. Blumenthal, Orna Aizenstein, Felix Bokstein, Dafna Ben Bashat · 2018 · Journal of Magnetic Resonance Imaging
51. Institutional Implementation of a Structured Reporting System: Our Experience with the Brain Tumor Reporting and Data System
    Ashwani Gore, Michael J. Hoch, Hui‐Kuo G. Shu, Jeffrey J. Olson, Alfredo Daniel Voloschin, Brent D. Weinberg · 2019 · Academic Radiology
52. Current and Future Imaging Methods for Evaluating Response to Immunotherapy in Neuro-Oncology
    Benjamin B. Kasten, Neha Udayakumar, Jianmei Wu Leavenworth, Anna M. Wu, Suzanne E. Lapi, Jonathan McConathy, Anna G. Sorace, Asim Kumar Bag, James M. Markert, Jason M. Warram · 2019 · Theranostics
53. INVITED REVIEW—NEUROIMAGING RESPONSE ASSESSMENT CRITERIA FOR BRAIN TUMORS IN VETERINARY PATIENTS
    John Henry Rossmeisl, Paulo A. Garcia, Gregory B. Daniel, John Daniel Bourland, Waldemar Debinski, Nikolaos G. Dervisis, Shawna L. Klahn · 2013 · Veterinary Radiology & Ultrasound
54. EFFECTS OF DRUG EFFLUX ON CONVECTION-ENHANCED PACLITAXEL DELIVERY TO MALIGNANT GLIOMAS
    Philipp G. Tanner, Markus Holtmannspötter, Jörg‐Christian Tonn, Roland Goldbrunner · 2007 · Neurosurgery
55. Temozolomide single-agent chemotherapy for newly diagnosed anaplastic oligodendroglioma
    Tom Mikkelsen, Thomas J. Doyle, John E. Anderson, Jeffrey Margolis, Nina A. Paleologos, J. Gutierrez, David J. Croteau, Laura A. Hasselbach, Rita Avedissian, L. Schultz · 2008 · Journal of Neuro-Oncology
56. Phase II trial of ritonavir/lopinavir in patients with progressive or recurrent high-grade gliomas
    Manmeet Singh Ahluwalia, Carol Patton, Glen H. J. Stevens, Tanya M. Tekautz, Lilyana Angelov, Michael A. Vogelbaum, Robert John Weil, Sam T. Chao, Paul J. Elson, John H. Suh et al. · 2010 · Journal of Neuro-Oncology
57. Clinical use of genotype to predict chemosensitivity in oligodendroglial tumors
    Carol A Walker, Brian J. Haylock, David John Husband, K A Joyce, Diane Fildes, Michael D. Jenkinson, T. Smith, John C. Broome, Daniel G. du Plessis, Peter C. Warnke · 2006 · Neurology
58. Phase II trial of docetaxel in patients with recurrent malignant glioma: a study of the National Cancer Institute of Canada Clinical Trials Group
    Peter A. Forsyth, G. Cairncross, David Stewart, Michael D E Goodyear, Nancy Wainman, Elisabeth Eisenhauer · 1996 · Investigational New Drugs
59. Conventional radiotherapy combined with carbogen breathing and nicotinamide for malignant gliomas
    Richard W.M. van der Maazen, H.O.M. Thijssen, Johannes H.A.M. Kaanders, A. de Koster, A. Keyser, Mathé J. J. Prick, J. André Grotenhuis, Pieter Wesseling, A.J. van der Kogel · 1995 · Radiotherapy and Oncology
60. Prospective evaluation of angiogenic, hypoxic and EGFR‐related biomarkers in recurrent glioblastoma multiforme treated with cetuximab, bevacizumab and irinotecan
    Benedikte Hasselbalch, Jesper Grau Eriksen, Helle Broholm, Ib Jarle Christensen, Kirsten Grunnet, Michael R. Horsman, Hans Skovgaard Poulsen, Marie‐Thérése Stockhausen, Ulrik Lassen · 2010 · Apmis
61. A new strategy of CyberKnife treatment system based radiosurgery followed by early use of adjuvant bevacizumab treatment for brain metastasis with extensive cerebral edema
    Yang Wang, Enmin Wang, Li Pan, Jiazhong Dai, Nan Zhang, Xin Wang, Xiaoxia Liu, Guanghai Mei, Xiaofang Sheng · 2014 · Journal of Neuro-Oncology
62. The role of salvage reirradiation for malignant gliomas that progress on bevacizumab
    Roy Torcuator, Ravneet Thind, Mehul K. Patel, Yedathore S. Mohan, Joseph Anderson, Thomas J. Doyle, Samuel Ryu, Rajan Jain, Lonni R Schultz, Mark Rosenblum et al. · 2009 · Journal of Neuro-Oncology
63. A phase II study of cisplatin and temozolomide in heavily pre-treated patients with temozolomide-refractory high-grade malignant glioma.
    Fable Zustovich, Giuseppe Lombardi, Alessandro Della Puppa, Antonino Rotilio, Renato Scienza, Davide Pastorelli · 2009 · PubMed
64. Serial analysis of imaging parameters in patients with newly diagnosed glioblastoma multiforme
    Yan Li, Janine Lupo, M.-Y. Polley, Jason C. Crane, Wei Bian, Soonmee Cha, Susan Marina Chang, Sarah J. Nelson · 2011 · Neuro-Oncology
65. Nonlinear registration of diffusion‐weighted images improves clinical sensitivity of functional diffusion maps in recurrent glioblastoma treated with bevacizumab
    Benjamin M. Ellingson, Timothy Francis Cloughesy, Albert Lai, Phioanh Leia Nghiemphu, Whitney B. Pope · 2011 · Magnetic Resonance in Medicine
66. Role of MRI in Primary Brain Tumor Evaluation
    Denise Leung, Xiaosi Han, Tom Mikkelsen, Burt Nabors · 2014 · Journal of the National Comprehensive Cancer Network
67. Consensus recommendations on standardized magnetic resonance imaging protocols for multicenter canine brain tumor clinical trials
    Rebecca A. Packer, John Henry Rossmeisl, Michael Sean Kent, John F. Griffin, Christina N. Mazcko, Amy Kathleen LeBlanc · 2018 · Veterinary Radiology & Ultrasound
68. Comparative evaluation of a novel, moderately hypofractionated radiation protocol in 56 dogs with symptomatic intracranial neoplasia
    P Schwarz, Valeria Meier, Alena Soukup, Randi Drees, Jürgen Besserer, Katrin Melanie Beckmann, Małgorzata Roos, Carla Rohrer Bley · 2018 · Journal of Veterinary Internal Medicine
69. Reirradiation of recurrent high-grade glioma and development of prognostic scores for progression and survival
    Christopher H. Chapman, Jared H. Hara, Annette M. Molinaro, Jennifer Leigh Clarke, Nancy Ann Oberheim Bush, Jennie Webster Taylor, Nicholas Arthur Butowski, Susan Marina Chang, Shannon E. Fogh, Penny K. Sneed et al. · 2019 · Neuro-Oncology Practice
70. Radiotherapy and chemotherapy of brain metastases
    Riccardo Soffietti, Alessandra Costanza, E. Laguzzi, M. Nobile, Roberta Rudà · 2005 · Journal of Neuro-Oncology
71. Up-front chemotherapy with fotemustine (F)/cisplatin (CDDP)/etoposide (VP16) regimen in the treatment of 33 non-removable glioblastomas
    Marc Frénay, Christine Lebrun‐Frénay, M. Lonjon, Pierre‐Yves Bondiau, Marcel Chatel · 2000 · European Journal of Cancer
72. Optimal treatment of leptomeningeal spread in glioblastoma: analysis of risk factors and outcome
    Jung-Hoon Noh, Min Ho Lee, Won Seog Kim, Do Hoon Lim, Sung Tae Kim, Doo‐Sik Kong, Do‐Hyun Nam, Jung-Il Lee, Ho Jun Seol · 2015 · Acta Neurochirurgica
73. Stereotactic brachytherapy of low-grade cerebral glioma after tumor resection
    Bogdana Suchorska, Maximilian Ingolf Ruge, Harald Treuer, V. Sturm, Jürgen Voges · 2011 · Neuro-Oncology
74. Multicentre phase II and pharmacokinetic study of RFS2000 (9-nitro-camptothecin) administered orally 5 days a week in patients with glioblastoma multiforme
    Éric Raymond, Mario Campone, Roger Stupp, Johan J Menten, Philippe J. M. Chollet, Thierry Lesimple, R. Féty, Denis Lacombe, Xavier Paolettí, P. Fumoleau · 2002 · European Journal of Cancer
75. Phase I study of temozolomide and escalating doses of oral etoposide for adults with recurrent malignant glioma
    David Nathan Korones, Michal Benita‐Weiss, Thomas Coyle, Laszlo L. Mechtler, Peter Walter Bushunow, Brandon Evans, David A. Reardon, Jennifer A. Quinn, Henry S. Friedman · 2003 · Cancer
76. Phase 2 study of bosutinib, a Src inhibitor, in adults with recurrent glioblastoma
    Jennie Webster Taylor, Jörg Dietrich, Elizabeth Robins Gerstner, Andrew David Norden, Mikael L. Rinne, Daniel P. Cahill, Anat O Stemmer-Rachamimov, Patrick Yung Wen, Rebecca A. Betensky, Diana H. Giorgio et al. · 2014 · Journal of Neuro-Oncology
77. Procarbazine, lomustine and vincristine for recurrent high-grade glioma
    Saurabh Parasramka, Goutham Talari, Myrna R. Rosenfeld, Jing Guo, John Lee Villano · 2017 · Cochrane Database of Systematic Reviews
78. Semi-Automatic Segmentation Software for Quantitative Clinical Brain Glioblastoma Evaluation
    Ying Zhu, Geoffrey S. Young, Zhong Xue, Raymond Y. Huang, Hui You, Kian Setayesh, Hiroto Hatabu, Fei F. Cao, Stephen T. C. Wong · 2012 · Academic Radiology
79. Phase I trial of temozolomide plus O6-benzylguanine 5-day regimen with recurrent malignant glioma
    Jennifer A. Quinn, Xiaoyin “Sara” Jiang, David A. Reardon, Annick Desjardins, James J. Vredenburgh, Jeremy N. Rich, Sridharan Gururangan, Allan H. Friedman, Darell D. Bigner, John Howard Sampson et al. · 2009 · Neuro-Oncology
80. Early biomarkers from dynamic contrast-enhanced magnetic resonance imaging to predict the response to antiangiogenic therapy in high-grade gliomas
    Francesca Piludu, Simona Marzi, Andrea Pace, Veronica Villani, Alessandra Fabi, C. M. Carapella, Irene Terrenato, Anna Antenucci, Antonello Vidiri · 2015 · Neuroradiology
81. Feasibility, phase I, and phase II studies of tandutinib, an oral platelet-derived growth factor receptor-β tyrosine kinase inhibitor, in patients with recurrent glioblastoma
    Tracy T. Batchelor, Elizabeth Robins Gerstner, Xiaobu Ye, Serena Desideri, Dan Gabriel Duda, David M. Peereboom, Glenn Jay Lesser, Sajeel A. Chowdhary, Patrick Yung Wen, Stuart A. Grossman et al. · 2016 · Neuro-Oncology
82. Classification of High-Grade Glioma into Tumor and Nontumor Components Using Support Vector Machine
    Deborah T. Blumenthal, Moran Artzi, Gilad Liberman, Felix Bokstein, Orna Aizenstein, Dafna Ben Bashat · 2017 · American Journal of Neuroradiology
83. Contribution of Different Positron Emission Tomography Tracers in Glioma Management: Focus on Glioblastoma
    Aurélie Moreau, Olivia Febvey‐Combes, Thomas Mognetti, Didier Frappaz, David Kryza · 2019 · Frontiers in Oncology
84. Potential of chemo-immunotherapy and radioimmunotherapy in relapsed primary central nervous system (CNS) lymphoma
    Nancy Diane Doolittle, Kristoph Jahnke, Richard Belanger, Deborah A. Ryan, Robert W. Nance, Cynthia A. Lacy, Rose Marie Tyson, Marianne Haluska, Nancy A. Hedrick, Csanád G. Várallyay et al. · 2007 · Leukemia & lymphoma/Leukemia and lymphoma
85. A phase I study of temozolomide and everolimus (RAD001) in patients with newly diagnosed and progressive glioblastoma either receiving or not receiving enzyme-inducing anticonvulsants: an NCIC CTG study
    Warren P. Mason, Mary Valeria MacNeil, Petr Kavan, Jacob C. Easaw, David R. Macdonald, Brian Arthur Thiessen, Shweta Urva, Zarnie Lwin, L. McIntosh, Elizabeth A. Eisenhauer · 2011 · Investigational New Drugs
86. The Predictive but Not Prognostic Value of MGMT Promoter Methylation Status in Elderly Glioblastoma Patients: A Meta-Analysis
    Anan Yin, Luhua Zhang, Jinxiang Cheng, Yu Hao Dong, Bo-lin Liu, Ning Han, Xiang Zhang · 2014 · PLoS ONE
87. Angiogenesis in Glioma
    Oliver Bögler, Tom Mikkelsen · 2003 · The Cancer Journal
88. European Organization for Research and Treatment of Cancer (EORTC) open label phase II study on glufosfamide administered as a 60-minute infusion every 3 weeks in recurrent glioblastoma multiforme
    Martin J. van den Bent, Wolfgang Grisold, Didier Frappaz, Roger Stupp, J.P. Desir, Thierry Lesimple, C. Dittrich, Maja J.A. de Jonge, Alba Ariela Brandes, Marc Frénay et al. · 2003 · Annals of Oncology
89. Molecularly targeted therapies for malignant gliomas: advances and challenges
    Marta Peñas-Prado, Mark R. Gilbert · 2007 · Expert Review of Anticancer Therapy
90. Second Line Chemotherapy with Docetaxel in Patients with Recurrent Malignant Glioma: A Phase II Study
    Marc Sanson, Massimo Napolitano, Ricardo Yayá, Florence Keime-Guibert, Philippe Broët, Khê Hoang‐Xuan, Jean‐Yves Delattre · 2000 · Journal of Neuro-Oncology
91. Salvage Chemotherapy with Taxol for Recurrent Anaplastic Astrocytomas
    Marc C. Chamberlain, Patty A. Kormanik · 1999 · Journal of Neuro-Oncology
92. Response Assessment in Neuro-Oncology Criteria: Implementation Challenges in Multicenter Neuro-Oncology Trials
    Whitney B. Pope, Colin Hessel · 2011 · American Journal of Neuroradiology
93. Blood-based biomarkers for malignant gliomas
    Matthias Holdhoff, Susannah G. Ellsworth, Osei Boadu, Stuart A. Grossman · 2013 · Journal of Neuro-Oncology
94. Impact of imaging measurements on response assessment in glioblastoma clinical trials
    David A. Reardon, KV Ballman, J. C. Buckner, Susan Marina Chang, Benjamin M. Ellingson · 2014 · Neuro-Oncology
95. The Impact of Extent of Resection and Histological Subtype on the Outcome of Adult Patients with High-grade Gliomas
    Shigeru Yamaguchi, H. Kobayashi, Shunsuke Terasaka, N. Ishii, Junichi Ikeda, Hiromi Kanno, Hiroshi Nishihara, Shinya Tanaka, Kiyohiro Houkin · 2012 · Japanese Journal of Clinical Oncology
96. The diagnostic performance of perfusion MRI for differentiating glioma recurrence from pseudoprogression
    Bing Wan, Siqi Wang, Mengqi Tu, Bo Wu, Ping Han, Haibo Xu · 2017 · Medicine
97. Recurrent glioblastomas in the elderly after maximal first-line treatment: does preserved overall condition warrant a maximal second-line treatment?
    On the Behalf of the Club de Neuro-Oncologie of the Société Française de Neurochirurgie, Marc Zanello, Alexandre Roux, Rénata Ursu, Sophie Peeters, Luc Bauchet, Georges Noël, Jacques Guyotat, Pierre‐Jean Le Reste, Thierry Faillot et al. · 2017 · Journal of Neuro-Oncology
98. Overexpression of cytosolic, plasma membrane bound and extracellular heat shock protein 70 (Hsp70) in primary glioblastomas
    Jun Thorsteinsdottir, Stefan Stangl, Peng Fu, Ke‐Tai Guo, Valerie S. Albrecht, Sabina Eigenbrod, Janina Erl, Mathias Gehrmann, Jörg‐Christian Tonn, Gabriele Multhoff et al. · 2017 · Journal of Neuro-Oncology
99. Diffusion Histology Imaging Combining Diffusion Basis Spectrum Imaging (DBSI) and Machine Learning Improves Detection and Classification of Glioblastoma Pathology
    Zezhong Ye, Richard L. Price, Xiran Liu, Joshua Yao-Yu Lin, Qingsong Yang, Peng Sun, Anthony T. Wu, Liang You Wang, Rowland H. Han, Chunyu Song et al. · 2020 · Clinical Cancer Research
100. Value of dynamic contrast perfusion MRI to predict early response to bevacizumab in newly diagnosed glioblastoma: results from ACRIN 6686 multicenter trial
     Schmainda, Kathleen M, Prah, Melissa A, Marques, Helga, Kim, Eunhee, Barboriak, Daniel P, Boxerman, Jerrold L · 2021 · Neuro-Oncology